5. Conclusions
myopic
To the best of our knowledge, this is the first randomized clinical study to assess the benefits of lutein supplementation in highly myopic individuals. Our findings showed significant benefits of lutein supplementation in MPOD augmentation in patients with HM. As this study included patients who underwent 6 months of follow-up, this might limit the evaluation of the extended effects. Further larger-scale and longer-term studies are required to strengthen these associations and evaluate the effects of lutein on visual function in patients with HM.